January 29, 2015
Astellas Pharma and Takeda Pharmaceutical will top Japan’s pharmaceutical market in FY2018 ending in March 2019, with other companies trailing the pair from far behind, a veteran Citi analyst predicted in an interview with Jiho. “Takeda’s earnings will bounce back,...read more